secwatch.observer — SEC 8-K summary
======================================

Issuer:     Stablecoin Development Corp (SDEV)
CIK:        0001389545
Form:       8-K
Filed at:   2026-02-20T23:59:59+00:00
Accession:  0001437749-26-004922
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 3.03, 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

NovaBay Pharmaceuticals effects 1-for-5 reverse stock split
-----------------------------------------------------------

- Reverse stock split effective at 4:15 p.m. ET on Feb 20, 2026; trading on split-adjusted basis from Feb 23.
- Ratio 1-for-5; no fractional shares issued (additional whole share provided for fractions).
- Authorized shares unchanged at 1.5 billion; par value remains $0.01 per share.
- Trading symbol unchanged as 'NBY'; new CUSIP number 66987P508.
- Stockholder approval obtained Oct 16, 2025; Board approved ratio on Feb 11, 2026.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1389545/000143774926004922/0001437749-26-004922-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1389545/000143774926004922/nby20260219_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-26-004922

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer